NO945094D0 - Anvendelse av bradykininantagonister for fremstilling av legemidler for behandling av virussykdommer - Google Patents

Anvendelse av bradykininantagonister for fremstilling av legemidler for behandling av virussykdommer

Info

Publication number
NO945094D0
NO945094D0 NO945094A NO945094A NO945094D0 NO 945094 D0 NO945094 D0 NO 945094D0 NO 945094 A NO945094 A NO 945094A NO 945094 A NO945094 A NO 945094A NO 945094 D0 NO945094 D0 NO 945094D0
Authority
NO
Norway
Prior art keywords
treatment
drugs
manufacture
viral diseases
bradykinin antagonists
Prior art date
Application number
NO945094A
Other languages
English (en)
Other versions
NO945094L (no
NO317660B1 (no
Inventor
Klaus Wirth
Irvin Winkler
Fred Lembeck
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO945094D0 publication Critical patent/NO945094D0/no
Publication of NO945094L publication Critical patent/NO945094L/no
Publication of NO317660B1 publication Critical patent/NO317660B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19945094A 1993-12-31 1994-12-30 Anvendelse av bradykininantagonister i kombinasjon med minst ett ytterligere antivirusmiddel for fremstilling av legemidler for behandling av virussykdommer. NO317660B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (3)

Publication Number Publication Date
NO945094D0 true NO945094D0 (no) 1994-12-30
NO945094L NO945094L (no) 1995-07-03
NO317660B1 NO317660B1 (no) 2004-11-29

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19945094A NO317660B1 (no) 1993-12-31 1994-12-30 Anvendelse av bradykininantagonister i kombinasjon med minst ett ytterligere antivirusmiddel for fremstilling av legemidler for behandling av virussykdommer.

Country Status (21)

Country Link
US (1) US5789383A (no)
EP (1) EP0661058B1 (no)
JP (1) JP3828593B2 (no)
KR (1) KR100358822B1 (no)
CN (1) CN1119171C (no)
AT (1) ATE255417T1 (no)
AU (1) AU696629B2 (no)
BR (1) BR9405308A (no)
CA (1) CA2138933C (no)
DE (2) DE4345062A1 (no)
DK (1) DK0661058T3 (no)
ES (1) ES2211874T3 (no)
FI (1) FI117320B (no)
HU (1) HU226374B1 (no)
IL (1) IL112183A (no)
MY (1) MY112888A (no)
NO (1) NO317660B1 (no)
PT (1) PT661058E (no)
RU (1) RU2228195C2 (no)
UA (1) UA41326C2 (no)
ZA (1) ZA9410381B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (en) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing
CN116731101A (zh) 2016-06-01 2023-09-12 雅斯娜 用于治疗多种疾病的n-己酸-l-酪氨酸-l-异亮氨酸-(6)-氨基己酰胺的衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
EP0586613A4 (en) * 1991-04-01 1994-08-24 Cortech Inc Bradykinin antagonists
ATE169823T1 (de) * 1991-04-19 1998-09-15 Scios Nova Inc Bradykinin typische peptide
EP0618810B1 (en) * 1991-04-19 2001-07-04 Scios Nova Inc. Bradykinin antagonist peptides
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds

Also Published As

Publication number Publication date
NO945094L (no) 1995-07-03
DE59410340D1 (de) 2004-01-15
UA41326C2 (uk) 2001-09-17
RU2228195C2 (ru) 2004-05-10
JP3828593B2 (ja) 2006-10-04
ATE255417T1 (de) 2003-12-15
PT661058E (pt) 2004-04-30
FI950010A0 (fi) 1995-01-02
KR100358822B1 (ko) 2003-01-24
EP0661058B1 (de) 2003-12-03
DE4345062A1 (de) 1995-07-13
FI950010A (fi) 1995-07-01
EP0661058A1 (de) 1995-07-05
ZA9410381B (en) 1995-08-29
MY112888A (en) 2001-10-31
HU9403783D0 (en) 1995-02-28
IL112183A (en) 2001-01-11
ES2211874T3 (es) 2004-07-16
CN1119171C (zh) 2003-08-27
US5789383A (en) 1998-08-04
JPH07206703A (ja) 1995-08-08
AU8179194A (en) 1995-07-13
RU94045140A (ru) 1996-10-20
KR950016779A (ko) 1995-07-20
CA2138933A1 (en) 1995-07-01
CA2138933C (en) 2010-02-23
AU696629B2 (en) 1998-09-17
HUT71422A (en) 1995-11-28
IL112183A0 (en) 1995-03-15
CN1108138A (zh) 1995-09-13
DK0661058T3 (da) 2004-04-05
FI117320B (fi) 2006-09-15
HU226374B1 (en) 2008-10-28
BR9405308A (pt) 1995-09-19
NO317660B1 (no) 2004-11-29

Similar Documents

Publication Publication Date Title
KR900009625A (ko) 피리미딘류 및 그의 약리학적으로 허용되는 염류 및 그 용도
FI862011A (fi) Terapeutiska nukleosider.
NO933077L (no) Anvendelse av IL-4-reseptor for terapi i profylakse og diagnostikk av allergiske, virale og parasitiske og bakterielle sykdommer
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
DK678887D0 (da) Farmaceutiske praeparater
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO914986D0 (no) Fremgangsmaate for fremstilling av anti-herpescastanosperminestere
NO945094D0 (no) Anvendelse av bradykininantagonister for fremstilling av legemidler for behandling av virussykdommer
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
DE59309732D1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
ATE183090T1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids

Legal Events

Date Code Title Description
MK1K Patent expired